ORIC Pharmaceuticals (ORIC) News Today

$8.27

+0.37 (+4.68%)

(As of 12/1/2023 ET)

Today's Range: $7.65
▼
$8.30
50-Day Range: $5.41
▼
$8.27
52-Week Range: $2.91
▼
$9.79

Volume: 412,571 shs
Average Volume: 371,698 shs
Market Capitalization: $451.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $16.29

Source

Source	Headline
	ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Buy" from Analysts americanbankingnews.com - November 24 at 1:24 AM
	ORIC Pharmaceuticals Inc ORIC morningstar.com - November 9 at 8:00 PM
	Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Oric Pharmaceuticals (ORIC) and Acadia Healthcare (ACHC) markets.businessinsider.com - November 8 at 2:03 PM
	ORIC Pharmaceuticals GAAP EPS of -$0.44 msn.com - November 6 at 9:49 PM
	ORIC Pharmaceuticals Inc (ORIC) Reports Q3 2023 Financial Results and Operational Updates finance.yahoo.com - November 6 at 9:49 PM
	ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates finance.yahoo.com - November 6 at 4:49 PM
	ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533 in Multiple Myeloma at the 65th American Society of Hematology (ASH) Annual Meeting finance.yahoo.com - November 2 at 9:17 AM
	Wedbush Reiterates ORIC Pharmaceuticals (ORIC) Outperform Recommendation msn.com - October 23 at 10:05 PM
	Analyst Expectations for ORIC Pharmaceuticals's Future markets.businessinsider.com - October 23 at 12:05 PM
	Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR and HER2 Exon 20 Mutations Demonstrates Potential Best-In-Class Profile finance.yahoo.com - October 21 at 12:45 PM
	ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023 finance.yahoo.com - October 17 at 8:27 PM
	Oric Pharmaceuticals, Inc. (ORIC) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com - October 16 at 2:01 PM
	NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD finance.yahoo.com - September 26 at 11:41 AM
	ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference benzinga.com - September 20 at 7:47 PM
	ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference finance.yahoo.com - September 20 at 7:47 PM
	Navigating ORIC's Robust Strategy Against Cancer Drug Resistance msn.com - September 13 at 9:18 PM
	Atom Investors LP Decreases Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) marketbeat.com - September 11 at 6:26 AM
	Oric Pharmaceuticals (ORIC) Receives a Buy from Robert W. Baird markets.businessinsider.com - August 17 at 8:10 AM
	Baird Maintains ORIC Pharmaceuticals (ORIC) Outperform Recommendation msn.com - August 16 at 10:10 PM
	H.C. Wainwright Sticks to Its Buy Rating for Oric Pharmaceuticals (ORIC) markets.businessinsider.com - August 15 at 8:13 AM
	Markets Today: Stocks Fall on a Hot U.S. July PPI msn.com - August 11 at 3:50 PM
	ORIC Pharmaceuticals GAAP EPS of -$0.50 beats by $0.08 msn.com - August 11 at 6:56 AM
	ORIC Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates finance.yahoo.com - August 11 at 1:55 AM
	Victory Capital Management Inc. Purchases New Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) marketbeat.com - August 10 at 5:12 AM
	ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - August 4 at 7:19 PM
	Jacob Chacko Sells 4,336 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock marketbeat.com - July 7 at 5:36 PM
	Why Oric Pharmaceuticals Stock Is Shooting Higher Today markets.businessinsider.com - June 28 at 9:46 AM
	Why Shares of Oric Pharmaceuticals Jumped Monday finance.yahoo.com - June 26 at 5:40 PM
	ORIC Pharmaceuticals launches ~$85M private placement of shares, warrants seekingalpha.com - June 26 at 12:39 PM
	ORIC Pharma Surges On $85 Mln Private Placement Financing markets.businessinsider.com - June 26 at 12:39 PM
	ORIC Pharmaceuticals Announces $85 Million Private Placement Financing finance.yahoo.com - June 26 at 12:39 PM
	HC Wainwright & Co. Reiterates ORIC Pharmaceuticals (ORIC) Buy Recommendation msn.com - June 8 at 6:17 PM
	Cornercap Investment Counsel Inc. Sells 22,606 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) marketbeat.com - June 2 at 8:26 AM
	ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference finance.yahoo.com - May 31 at 4:39 PM
	HC Wainwright & Co. Maintains ORIC Pharmaceuticals (ORIC) Buy Recommendation msn.com - May 12 at 10:43 AM
	ORIC Pharmaceuticals, Inc. Forecasted to Post Q2 2023 Earnings of ($0.59) Per Share (NASDAQ:ORIC) marketbeat.com - May 12 at 7:55 AM
	ORIC Pharmaceuticals GAAP EPS of -$0.53 msn.com - May 8 at 9:21 PM
	ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates finance.yahoo.com - May 8 at 4:21 PM
	ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - May 5 at 7:16 PM
	Bank of Montreal Can Invests $636,000 in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) marketbeat.com - May 1 at 4:49 AM
	ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Investor Conference finance.yahoo.com - April 25 at 6:47 PM
	Monaco Asset Management SAM Raises Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) marketbeat.com - April 20 at 4:53 AM
	ORIC Pharmaceuticals Presents Promising Preclinical Data on Two Programs at the 2023 American Association for Cancer Research (AACR) Annual Meeting finance.yahoo.com - April 18 at 8:32 PM
	Citigroup Maintains ORIC Pharmaceuticals (ORIC) Buy Recommendation msn.com - April 6 at 9:00 AM
	One ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) insider upped their stake by 128% in the previous year finance.yahoo.com - March 31 at 12:42 PM
	‘Charts Point to Higher Highs,’ Says Oppenheimer. Here Are 2 Stocks With Over 100% Upside Potential finance.yahoo.com - March 29 at 11:50 PM
	Q1 2023 Earnings Estimate for ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Issued By HC Wainwright marketbeat.com - March 24 at 6:17 AM
	4 Analysts Have This to Say About ORIC Pharmaceuticals markets.businessinsider.com - March 23 at 12:01 PM
	ORIC Pharmaceuticals (NASDAQ:ORIC) Given New $15.00 Price Target at JPMorgan Chase & Co. marketbeat.com - March 21 at 10:32 AM
	Analysts Offer Insights on Healthcare Companies: Neoleukin Therapeutics (NLTX), RAPT Therapeutics (RAPT) and Oric Pharmaceuticals (ORIC) markets.businessinsider.com - March 21 at 7:34 AM

Get ORIC Pharmaceuticals News Delivered to You Automatically

ORIC Media Mentions By Week

ORIC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ORIC
News Sentiment
▼
1.87

0.76
▲
Average
Medical
News Sentiment

ORIC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ORIC Articles
This Week
▼
1

1
▲
ORIC Articles
Average Week

Get ORIC Pharmaceuticals News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ORIC) was last updated on 12/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ORIC Pharmaceuticals (ORIC) News Today

ORIC Media Mentions By Week

ORIC Media Sentiment

ORIC News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info